Covered recipient · General Payments record
JOSEPH C BROOME
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,141.14
- Reported across 203 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $624.46 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $167.29 | 3 |
| ABBVIE INC. | $161.84 | 7 |
| Medtronic, Inc. | $85.85 | 4 |
| GlaxoSmithKline, LLC. | $59.18 | 4 |
| Abbott Laboratories | $32.31 | 2 |
| Lilly USA, LLC | $28.58 | 2 |
| Astellas Pharma US Inc | $28.25 | 2 |
| DEXCOM, INC. | $28.21 | 1 |
| Novo Nordisk AS | $17.45 | 1 |
| PFIZER INC. | $15.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.22 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124976727 | CMS |
| Abbott Laboratories | $16.09 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124976731 | CMS |
| ABBVIE INC. | $31.76 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103373427 | CMS |
| ABBVIE INC. | $33.39 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103373429 | CMS |
| ABBVIE INC. | $34.50 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103373431 | CMS |
| ABBVIE INC. | $9.41 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103373433 | CMS |
| ABBVIE INC. | $9.13 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103373435 | CMS |
| ABBVIE INC. | $34.86 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103373437 | CMS |
| ABBVIE INC. | $8.79 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103373439 | CMS |
| Astellas Pharma US Inc | $14.50 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139304698 | CMS |
| Astellas Pharma US Inc | $13.75 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139327970 | CMS |
| AstraZeneca Pharmaceuticals LP | $48.66 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105632598 | CMS |
| AstraZeneca Pharmaceuticals LP | $105.38 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104356889 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.25 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105892386 | CMS |
| Dexcom, Inc. | $28.21 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153311244 | CMS |
| GlaxoSmithKline, LLC. | $14.14 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115820244 | CMS |
| GlaxoSmithKline, LLC. | $14.13 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116372289 | CMS |
| GlaxoSmithKline, LLC. | $16.05 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115922237 | CMS |
| GlaxoSmithKline, LLC. | $14.86 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115766511 | CMS |
| Lilly USA, LLC | $14.64 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135101328 | CMS |
| Lilly USA, LLC | $13.94 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135105067 | CMS |
| Medtronic, Inc. | $15.82 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117153649 | CMS |
| Medtronic, Inc. | $36.63 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117153651 | CMS |
| Medtronic, Inc. | $15.90 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117153653 | CMS |
| Medtronic, Inc. | $17.50 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117153655 | CMS |
| Novo Nordisk Inc | $17.45 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096911291 | CMS |
| PFIZER INC. | $15.50 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131505816 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.